BNT162 Vaccine

mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech.

Also Known As:

BNT 162A1; BNT 162B1; BNT 162B2; BNT 162C2; COVID 19 Vaccine Pfizer BioNTech; Covid-19 Vaccine, Pfizer; Pfizer Covid 19 Vaccine; Pfizer-BioNTech, COVID-19 Vaccine; Vaccine Pfizer-BioNTech, COVID-19; Vaccine, BNT162; Vaccine, Pfizer Covid-19; Abdavomeran; BNT-162A1; BNT-162B1; BNT-162B2; BNT-162C2; BNT162A1; BNT162B1; BNT162B2; BNT162C2; COVID-19 Vaccine Pfizer-BioNTech; Comirnaty; Pfizer Covid-19 Vaccine; Pidacmeran; Tozinameran

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Recombinant Proteins: 2811
    - Synthetic Vaccines: 1084
      - Nucleic Acid-Based Vaccines: 116
        mRNA Vaccines: 3134
        BNT162 Vaccine: 2899
Complex Mixtures: 1947
- Biological Products
  - Vaccines: 128365
    - Synthetic Vaccines: 1084
      - Nucleic Acid-Based Vaccines: 116
        mRNA Vaccines: 3134
        BNT162 Vaccine: 2899
    - Viral Vaccines: 473
      - COVID-19 Vaccines: 8432
        BNT162 Vaccine: 2899
Biological Factors: 2560
- Antigens: 145631
  - Synthetic Vaccines: 1084
    - Nucleic Acid-Based Vaccines: 116
      - mRNA Vaccines: 3134
        BNT162 Vaccine: 2899

Luca Iannelli Selected Research

Luca Iannelli Research Topics

Disease

Drug/Important Bio-Agent (IBA)